Please Like Comment Share and Subscribe the Channel
Medical News
After learning from Coronavirus pandemic the Focus should be on Healthcare Budget says Dr Shuchin Bajaj
Views of Top Experts on Healthcare Budget 2021
According to Dr Shuchin Bajaj, Founder and Director, Ujala Cygnus Group of Hospitals, “As India faces the worst ever health crisis of all times, we hope that Covid-19 will provide the silver lining for increasing the healthcare budget. There has never been a greater spotlight on healthcare delivery in various environments. Unfortunately, no election has been fought on healthcare as an issue in India yet. But now, with the coronavirus pandemic, the focus is only and squarely on healthcare. I hope that this will lead to an increase in the healthcare budget and various healthcare provisions, so that the expenditure on health can go up to 3% of the GDP, as promised by the government.”
Healthcare is a national priority Govt. should invest more says Dr Ashutosh Raghuvanshi
Views of Top Experts s on Healthcare Budget 2021
“The Covid pandemic has underlined the importance of a higher budget allocation for healthcare more than anything else. A large part of previous budgets was dedicated towards making healthcare cheaper and more accessible, but the current situation demands an increased budget for improving healthcare infrastructure at the primary, secondary and tertiary levels, and also to propel healthcare sector recovery,” says Dr Ashutosh Raghuvanshi, COO, Fortis Healthcare.
“There are indications that the government is likely to increase healthcare spending in the forthcoming budget announcement on February 1. This is laudable as healthcare is a national priority sector today and we need a dedicated national health fund which can provide all necessary resources and support to fix existing gaps, upgrade healthcare infrastructure, equip district-level hospitals and primary health centres with oxygen supplies, increased beds and medical equipment. We also need to invest more in medical education and training to address the shortage of healthcare professionals in the country, and strengthen the operational modalities to boost digital health and telemedicine services,” he adds.
Dr Raghuvanshi also suggests, “In order to ensure that the credit chain remains intact and input taxes are not loaded on to the cost of healthcare services, the government may consider zero rating of GST for healthcare. There is also a need to upgrade skilling to increase capacities among healthcare workers. There is also an urgent need to review and implement national programmes on non-communicable diseases to tackle the increasing burden of heart diseases, diabetes, cancer and tuberculosis as well as to encourage preventive care.”
‘Make in India’ should be the focus in Health Budget 2021 says Rajiv Nath
Views of TOP experts on Healthcare Budget
During the Covid-19 crisis, India has also emerged as a supplier of ‘Made in India’ healthcare products and medical devices for other countries. About the matter, Rajiv Nath, Forum Coordinator at AIMED (Association of Indian Medical Devices Industry) says, “The onset of Covid exposed the soft underbelly of the healthcare insecurity in India with its huge over-dependence on imports. The nation had to undergo a lengthy lockdown as the country prepared to build the healthcare sector and procure medical devices, manufacturing infrastructure and inventory of vital Covid-related devices like ventilators, masks, thermometers and PPE kits. But consumers do not gain from low duties if they have to pay for misleading and artificially inflated MRP labelled medical devices and are exposed to inconsistent prices that are linked to a volatile currency exchange rate. If consumer interest is to be protected, capping the MRP at 4-5 times the import landed price is more effective than turning a blind eye to the MRP which is as high as 20-30 times the import landed price. Indian imports of Rs. 42,000 crores, which account for 85% of the medical device market are a healthcare security risk which needs to be addressed. This is also an opportunity for ‘Make in India’.”
He too speaks of expectations regarding taxation, explaining, “After GST, imported devices are cheaper by 11% and Indian manufacturers are challenged to compete with Chinese imports in government tenders even for basic products like syringes, thermometers, examination gloves and blood collection tubes.”
About sustaining the ‘Make in India’ model, he adds, “We seek nominal tariff protection for devices being made in the country and a predictable tariff policy, so if capacity is added by a manufacturer, there is assured nominal protection. To promote the domestic medical device industry, which will subsequently reduce India’s heavy reliance on imports, the current basic import tariff of 0-7.5% needs to be 15% for medical devices (the bound rate under WTO is 40% duty) and on their components, it needs to be at least 5%, and 7.5% next year as a PMP ‘Make in India’ enabler. Concessional duty on raw material may be retained at 2.5% for now and for the next three years.”
One doctor honored by Padma Vibhushan and 9 doctors receives Padma Shri
Padma Awards 2021 – Dr. Belle Monappa Hegde – Medicine from Karnataka gets Padma Vibhushan.
The leading cardiologist and educator from Udupi in Karnataka, Dr Belle Monappa Hegde has been honored by Padma Vibhushan award.Dr Hegde has been awarded the third highest civilian award ,Padma Bhushan , in 2010.
9 Doctors receives PADMA SHRI
Dr Ratan Lal Mittal – Department Medicine from Punjab
Dr Chandrakant Sambhaji Pandav – Department Medicine from Delhi
Dr J N Pande – Department Medicine from Delhi
Dr Krishan Mohan Pathi- Department Medicine from Odisha
Dr Dhananjay Diwakar – Department Medicine from Kerala
Dr Dilip Kumar Singh- Department Medicine from Bihar
Dr. Thiruvengadam Veeraraghavan – Department Medicine from Tamil Nadu
Shri Ashok Kumar Sahu- Department Medicine from Uttar Pradesh
Dr Kaushal Kant joins Fortis Escorts as a Director of Joint Replacement and Orthopaedics. He has expertise in Knee & Hip Joint Replacement, Revision Joint Replacement, Shoulder & Elbow Surgery, Pelvic Surgery, and Trauma.
He has done Fellowship from AIIMS in Joint Replacement. Arthroscopy & Sports Medicine Institute Fellowship from Mumbai and Fellowship in Orthopaedics from Bombay Hospital.
Dr. Kaushal was working in Primus hospital as Senior Consultant joint Replacement and trauma, & HOD Orthopaedics and Trauma. He also runs Knight Clinic, New Delhi.
He has various milestones and achievements. He has done the highest number of Hip Surgeries in Delhi for the last 4 years.
Fire broke out at Serum Institute of India (SII) took the life of five people in Pune
The Serum Institute of India (SII) is the largest vaccine manufacturer in India. The drugmaker company has also developed the Covid-19 vaccine COVISHIELD. A fire broke twice at the Serum Institute of India that took the life of five people. The fire broke at the vaccine maker’s Pune facility in a building that is under construction. But it is unlikely to hit the production of the coronavirus vaccine Covishield that is developed by the SII in partnership with the Oxford University and AstraZeneca.
“We have just received some distressing updates; upon further investigation we have learnt that there has unfortunately been some loss of life at the incident.We are deeply saddened and offere our deepest condolences to the family members of the departed,” The is tweeted by the SII Ceo Adar Poonawala.
Many injured were trapped in to the building but further they all rescued .It took around three hours for firemen to control the fire.The fire is believed to have started because of an electrical fault, but still its under investigation.
The Serum Institute has announced the compensation of 25 lakh to each of their families who dies in the incident.
Prime Minister Narendra Modi tweeted and said he was anguished by the loss of lives. The name of the complex is Manjari where the fire broke out. The Manjari complex has eight to nine buildings that is being constructed to deal with future pandemics to increase the manufacturing capability of the company.
Serum Institute makes vaccines against polio, Diptheria, tetanus, hepatitis B, Measles, mumps, and rubella these vaccines are exported to more than 170 countries in the World.
The National Medical Commission (NMC) has issued the circular regarding fake notice, circulars and Public Notice in name of National Medical Commission.
Alarming the MBBS students across the country and abroad.Please note that all-important letters, circulars, and Public Notice are posted on the National Medical Commission website www.nmc.org.in.It is advised to check the website of the NMC for genuine notice,circular and letters.Moreover, these are sent to the Sates/UT Govts, DMEs,VCs,Dean /Principals of medical Colleges and a copy is sent to the Ministry of Health and family Welfare, Govt .of India
More than half seats remain vacant in dental colleges of Maharashtra & Karnataka
The central government has extended the admissions deadline for undergraduate medical and dental seats till January 15 to fill up all vacant seats across the country. The Dental Council of India (DCI) has also extended the admissions deadline for the Bachelor of Dental Surgery (BDS) course until January 31
According to the information shared by the state common entrance test(CET) cell, almost 35% of seats-852 seats out of 2,400 seats in private dental colleges in Maharashtra remain vacant as of January 8.
The country has almost total 313 dental institutes and Karnataka has 44 seats.In Karnataka also nearly 60% BDS seats are vacant.
According to the Ministry of Fisheries, Animal Husbandry and Dairying in Delhi,rows and ducks were reported dead in New Delhi and Sanjay lake areas tested positive.
In Death of crow confirmed in Kotdwar & Dehradun districts of Uttarakhand. In Delhi, crows and ducks, respectively, were reported dead in New Delhi and Sanjay lake areas.